Articles

The TGA has issued a $12,600 infringement notice to Melbourne based company NutriPATH Pty Ltd for the alleged unlawful advertising of a COVID-19 Polymerase Chain Reaction (PCR) test collection kit.

Undertaking given to the Secretary of the Australian Government Department of Health for the purposes of section 42YL of the Act

The TGA has issued fifteen infringement notices totalling $37,800 to a doctor in Perth

Ads for health products are everywhere, but don't believe everything you read

The TGA has issued twelve infringement notices totalling $151,200 for the alleged unlawful advertising of Miracle Mineral Supplement and other medicines

From 1 July 2020, medicine advertisements in specified media do not need pre-approval from the TGA

Information updated

The TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits

The TGA has issued five infringement notices totalling $63,000 to a Queensland company for alleged breaches relating to COVID-19 test kits

Information on an exemption for radiopharmaceuticals that facilitates interstate supply during COVID-19

How to find information about the inactive ingredients in your medicines.

To improve access to important ingredient information, TGA publishes the names of excipients in medicines and biologicals on its website

The TGA has issued two infringement notices to Peter Evans' company totalling $25,200 for alleged breaches of therapeutic goods legislation in relation to the promotion of a 'BioCharger' device

The TGA has issued infringement notices totalling $25,200 to Queensland company CK Surgitech for alleged breaches relating to COVID-19 test kits

The TGA has issued an infringement notice for $12,600 to Labtest Direct for the alleged advertising of COVID-19 Rapid Test kits

The TGA has issued an infringement notice for $2,520 to a woman in Western Australia for alleged breaches relating to COVID-19 test kits

Clinicians need to tailor the device programming of CRT-D devices to each patient to ensure the delivery of therapy

The Federal Court granted the interim injunction on 3 April 2020

Interim statement concerning the use of GS1 Australia's Recall Health platform

This specification describes the minimal acceptable performance and desired features for a ventilator to be used in Australian hospitals during the current SARS-CoV2 outbreak.

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page

The TGA has issued ATP Science Pty Ltd with 24 infringement notices

The TGA has issued Oxymed Australia Pty Ltd five infringement notices for alleged advertising breaches

The TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19

Due to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice